Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Purchase |
2022-12-31 | 13G | Metacrine, Inc. MTCR |
TANG CAPITAL PARTNERS LP | 4,250,000 9.980% |
1,208,623 (+39.74%) |
Filing History |
| 2023-02-08 3:43 pm Purchase |
2023-02-08 | 13G | Metacrine, Inc. MTCR |
BML Investment Partners, L.P. | 6,767,458 15.900% |
278,493 (+4.29%) |
Filing History |
| 2022-12-19 4:00 pm Purchase |
2022-12-08 | 13G | Metacrine, Inc. MTCR |
TANG CAPITAL PARTNERS LP | 3,041,377 7.100% |
3,041,377 (New Position) |
Filing History |
| 2022-12-08 12:08 pm Purchase |
2022-12-08 | 13D | Metacrine, Inc. MTCR |
BML Investment Partners, L.P. | 6,488,965 15.200% |
976,799 (+17.72%) |
Filing History |
| 2022-10-26 5:59 pm Purchase |
2022-10-24 | 13G | Metacrine, Inc. MTCR |
BML Investment Partners, L.P. | 5,512,166 12.900% |
3,912,166 (+244.51%) |
Filing History |
| 2022-02-17 8:27 pm Purchase |
2022-02-11 | 13G | Metacrine, Inc. MTCR |
BML Investment Partners, L.P. | 1,600,000 5.900% |
1,600,000 (New Position) |
Filing History |
| 2022-02-14 2:33 pm Sale |
2021-12-31 | 13G | Metacrine, Inc. MTCR |
venBio Global Strategic Fund L.P. | 0 0.000% |
-3,059,123 (Position Closed) |
Filing History |
| 2022-02-11 4:17 pm Purchase |
2021-12-31 | 13G | Yumanity Therapeutics, Inc. YMTX |
ALEXANDRIA REAL ESTATE EQUITIES INC ARE |
112,051 2.900% |
112,051 (New Position) |
Filing History |
| 2022-02-04 2:47 pm Sale |
2021-12-31 | 13G | Metacrine, Inc. MTCR |
FRANKLIN RESOURCES INC BEN |
0 0.000% |
-1,309,057 (Position Closed) |
Filing History |
| 2022-01-05 2:42 pm Sale |
2021-12-27 | 13D | Metacrine, Inc. MTCR |
New Enterprise Associates 16, L.P. | 0 0.000% |
-3,060,527 (Position Closed) |
Filing History |
| 2021-02-16 4:53 pm Purchase |
2020-12-31 | 13G | Metacrine, Inc. MTCR |
venBio Global Strategic Fund L.P. | 3,059,123 11.800% |
3,059,123 (New Position) |
Filing History |
| 2021-02-12 6:11 pm Purchase |
2020-12-31 | 13G | Metacrine, Inc. MTCR |
ALEXANDRIA REAL ESTATE EQUITIES INC ARE |
1,307,256 5.000% |
1,307,256 (New Position) |
Filing History |
| 2021-02-12 5:25 pm Purchase |
2020-12-31 | 13G | Metacrine, Inc. MTCR |
Polaris Partners VII L.P. | 2,894,258 11.200% |
2,894,258 (New Position) |
Filing History |
| 2021-02-02 5:04 pm Purchase |
2020-12-31 | 13G | Metacrine, Inc. MTCR |
ARCH Venture Fund VIII L.P. | 2,940,503 11.300% |
2,940,503 (New Position) |
Filing History |
| 2021-02-02 12:52 pm Purchase |
2020-12-31 | 13G | Metacrine, Inc. MTCR |
FRANKLIN RESOURCES INC BEN |
1,309,057 5.000% |
1,309,057 (New Position) |
Filing History |
| 2020-09-29 4:06 pm Purchase |
2020-09-18 | 13G | Metacrine, Inc. MTCR |
Flynn James E | 927,469 3.580% |
927,469 (New Position) |
Filing History |
| 2020-09-28 2:18 pm Purchase |
2020-09-22 | 13D | Metacrine, Inc. MTCR |
New Enterprise Associates 16, L.P. | 3,060,527 11.800% |
3,060,527 (New Position) |
Filing History |